168 results on '"Pillet, Pascal"'
Search Results
2. Quand prescrire un bilan auto-immun chez l’enfant ?
3. Clinical spectrum and outcome of Takayasu's arteritis in children
4. JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach Study
5. Antinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus
6. Individual and environmental determinants associated with longer times to access pediatric rheumatology centers for patients with juvenile idiopathic arthritis, a JIR cohort study
7. Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotype
8. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
9. Systemic lupus international collaborating clinics-2012 and European league against rheumatism/American college of rheumatology-2019 classification criteria for systemic lupus erythematosus associated with childhood-onset auto-immune cytopenia.
10. L’alliance thérapeutique est associée à l’adhésion au traitement chez les enfants atteints d’arthrite juvénile idiopathique
11. Évènements indésirables infectieux chez des enfants atteints d’arthrite juvénile idiopathique et traités en vie réelle par biothérapies : données issues de la JIR cohorte
12. Therapeutic alliance is associated to treatment adherence in children with juvenile idiopathic arthritis
13. Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte
14. An updated overview of Juvenile Systemic Sclerosis in a French cohort
15. Antinuclear antibodies associated auto-immune cytopenia in childhood is a risk factor for systemic lupus erythematosus
16. Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
17. Systemic Corticosteroids for Autoimmune/Inflammatory Disorders in Children: Clinical Aspects
18. Conventional radiography in juvenile idiopathic arthritis: Joint recommendations from the French societies for rheumatology, radiology and paediatric rheumatology
19. Anakinra as first-line therapy for systemic onset juvenile idiopathic arthritis: a retrospective study in a French Single-center
20. Additional file 1 of Individual and environmental determinants associated with longer times to access pediatric rheumatology centers for patients with juvenile idiopathic arthritis, a JIR cohort study
21. Clinicians need to decrease antibiotic use in previously healthy infants hospitalised with bronchiolitis
22. Towards a new set of classification criteria for PFAPA syndrome
23. Transition de la médecine pédiatrique à la médecine pour adultes dans les maladies autoimmunes et autoinflammatoires rares
24. Fièvre récurrente de l’enfant : quand penser à une maladie auto-inflammatoire ?
25. Juvenile Idiopathic Arthritis and COVID-19 Pandemic: Good Compliance With Treatment, Reluctance to Return to School
26. Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review
27. Musculoskeletal Symptoms in Patients With Cryopyrin-Associated Periodic Syndromes: A Large Database Study
28. International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients
29. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
30. Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR Cohort
31. Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency
32. Novel proteasome assembly chaperone mutations in PSMG2/PAC2 cause the autoinflammatory interferonopathy CANDLE/PRAAS4
33. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
34. A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (Auto-Inflammatory Diseases Activity Index) Consensus Conference
35. Validation of the new classification criteria for hereditary recurrent fever in an independent cohort: experience from the JIR Cohort Database
36. PFAPA syndrome is not a sporadic disease
37. Efficacy of Etanercept for the Treatment of Juvenile Idiopathic Arthritis According to the Onset Type
38. A Syndrome Involving Intrauterine Growth Retardation, Microcephaly, Cerebellar Hypoplasia, B Lymphocyte Deficiency, and Progressive Pancytopenia.
39. The therapeutic alliance is associated with a better therapeutic adherence in children with juvenile idiopathic arthritis: reulsts of a French Multicenter Study
40. Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients
41. THU0534 NEW CLASSIFICATION CRITERIA FOR RECURRENT AUTOINFLAMMATORY DISEASES APPLIED TO AN INDEPENDENT COHORT: EXPERIENCE FROM THE JIR COHORT DATABASE
42. Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients
43. Validation of the French version of the Childhood Health Assessment Questionnaire (CHAQ) in juvenile idiopathic arthritis
44. Validation de la version française du Childhood Health Assessment Questionnaire (CHAQ) dans les arthrites juvéniles idiopathiques
45. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five cases
46. International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients
47. PFAPA syndrome is not a sporadic disease
48. Clinicians need to decrease antibiotic use in previously healthy infants hospitalised with bronchiolitis
49. Clinical dose effect and functional consequences of R92Q in two families presenting with a TRAPS/PFAPA‐like phenotype
50. First line therapy by Interleukin-1 teceptor antagonist in steroid naive children with systemic juvenile idiopathic arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.